 A STUDY OF ATEZOLIZUMAB IN COMBINATION WITH CARBOPLATIN OR CISPLATIN PEMETREXED COMPARED WITH CARBOPLATIN OR CISPLATIN PEMETREXED IN PARTICIPANTS WHO ARE CHEMOTHERAPY-NAIVE AND HAVE STAGE IV NON-SQUAMOUS NON-SMALL CELL LUNG CANCER NSCLC IMPOWER 132: 